Title 19 Promis

CIK: 0002005531

Transaction Breakdown

Open Market Buys (P)1 (14.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)6 (85.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PMN

ProMIS Neurosciences Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (7 total)

PMN
ProMIS Neurosciences Inc.
Jul 29, 2025
Purchase(P)
Warrants to Purchase Common Shares
Direct
539.1K shares-
PMN
ProMIS Neurosciences Inc.
Jul 25, 2025
In-the-Money(X)
Tranche A Common Share Purchase Warrants
Direct
119.8K shares-
PMN
ProMIS Neurosciences Inc.
Jul 25, 2025
In-the-Money(X)
Tranche B Common Share Purchase Warrants
Direct
119.8K shares-
PMN
ProMIS Neurosciences Inc.
Jul 25, 2025
In-the-Money(X)
Tranche C Common Share Purchase Warrants
Direct
119.8K shares-
PMN
ProMIS Neurosciences Inc.
Jul 25, 2025
In-the-Money(X)
Direct
119.8K shares-
PMN
ProMIS Neurosciences Inc.
Jul 25, 2025
In-the-Money(X)
Direct
119.8K shares-
PMN
ProMIS Neurosciences Inc.
Jul 25, 2025
In-the-Money(X)
Direct
119.8K shares-

		Type	Shares	Price		Ownership
Jul 29, 2025	PMN ProMIS Neurosciences Inc.	Purchase(P) Warrants to Purchase Common Shares	539,100	-	-	Direct
Jul 25, 2025	PMN ProMIS Neurosciences Inc.	In-the-Money(X) Tranche A Common Share Purchase Warrants	119,800	-	-	Direct
Jul 25, 2025	PMN ProMIS Neurosciences Inc.	In-the-Money(X) Tranche B Common Share Purchase Warrants	119,800	-	-	Direct
Jul 25, 2025	PMN ProMIS Neurosciences Inc.	In-the-Money(X) Tranche C Common Share Purchase Warrants	119,800	-	-	Direct
Jul 25, 2025	PMN ProMIS Neurosciences Inc.	In-the-Money(X)	119,800	-	-	Direct
Jul 25, 2025	PMN ProMIS Neurosciences Inc.	In-the-Money(X)	119,800	-	-	Direct
Jul 25, 2025	PMN ProMIS Neurosciences Inc.	In-the-Money(X)	119,800	-	-	Direct

1-7 of 7 transactions

About Title 19 Promis

Title 19 Promis (SEC CIK 0002005531) files insider reports with the SEC as 10% Owner of ProMIS Neurosciences Inc. (PMN).

Signal8 holds 2 ownership filings by Title 19 Promis, all Form 4s, filed between Jul 29, 2025 and Aug 14, 2025. Those filings report 7 transactions, from Jul 25, 2025 to Jul 29, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Title 19 Promis's filings is in BOSTON, MA.

Recent filings by Title 19 Promis

Jul 29, 2025: Open-market purchase of PMN derivative securities (Form 4, code P).
Jul 25, 2025: Option exercises of PMN derivative securities (6 lines, Form 4, code X).

Other insiders filing for ProMIS Neurosciences Inc. (PMN)

Williams Eugene, Director
Cashman Neil, Chief Scientific Officer
Rubino Ivana, Chief Commercial Officer
Kaplan Johanne, Chief Development Officer
WYMAN WILLIAM W, Director
Warma Neil K, Chief Executive Officer

How to read Form 4 transaction codes